S&P 500 Healthcare Sector SEC Filings — March 18, 2026

18-03-2026

ProMIS Neurosciences Inc. filed an S-3 shelf registration statement on March 18, 2026, to enable the resale of up to 13,830,592 common shares by selling securityholders from a January 29, 2026 private placement, consisting of 6,815,296 common shares, Common Share Warrants for 6,915,296 shares, and Pre-Funded Warrants for 100,000 shares. The company will not receive proceeds from resales but may from cash exercises of the warrants, and it bears the registration costs. Common shares closed at $20.16 on Nasdaq on March 16, 2026; the company qualifies as a smaller reporting company and emerging growth company.

• ·Registrant incorporated in Ontario, Canada (I.R.S. Employer ID: 98-0647155).
• ·Principal executive offices: Suite 200, 1920 Yonge Street, Toronto, Ontario M4S 3E2.
• ·Agent for service: C T Corporation System, 1015 15th Street N.W., Suite 1000, Washington, D.C. 20005.
• ·Securities to be offered on a delayed or continuous basis pursuant to Rule 415.
• ·Non-accelerated filer, smaller reporting company, and emerging growth company (not electing extended transition period for new accounting standards).

18-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 18, 2026, announcing the issuance of a press release titled 'AITX's RAD Unveils Rebuilt radsecurity.com'. The press release is attached as Exhibit 99.1 under Item 9.01. The filing is furnished under Item 8.01 and not deemed filed for liability purposes.

18-03-2026

CVB Financial Corp filed a Form 8-K on March 18, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial metrics, transactions, or impacts are disclosed in the provided filing information. The filing has Accession Number 0001193125-26-111638 and size of 555 KB.

• ·Sector: not specified
• ·Event Type: General Filing
• ·Source: us_sec

18-03-2026

News Corporation filed an 8-K on March 18, 2026, disclosing information provided to the Australian Securities Exchange (ASX) on March 17, 2026, regarding its ongoing $1 billion stock repurchase program for Class A (NWSA) and Class B (NWS) common stock. The program authorizes repurchases up to $1B in aggregate, with daily ASX disclosures required for any transactions. Exhibits 99.1 and 99.2 contain the specific ASX disclosures; no new transactions or program changes are detailed in the filing body.

18-03-2026

New Era Energy & Digital, Inc. appointed Ted Warner as Chief Financial Officer effective March 16, 2026, with E. Will Gray II transitioning back to sole CEO role from interim CFO. Warner's package includes a $500K annual base salary, target bonus up to 40% ($200K), potential $200K additional bonus, 1.22M PSUs vesting over five years, and 610.7K RSUs vesting over four years. The appointment involves no family relationships, conflicts, or prior arrangements requiring disclosure.

• ·Ted Warner, age 45, previously Managing Director at Northland Capital Markets since 2020; holds Series 7, 79, 63 licenses, B.A. from University of Michigan, MBA from University of Minnesota.
• ·Severance terms: 100% base salary (pre-CIC) or 150% (post-CIC), plus bonuses and benefits continuation.
• ·Restrictive covenants: 18-month non-solicit clients, 24-month non-solicit employees.

18-03-2026

Pacific Health Care Organization Inc (PFHO) reported total revenues of $6.7M for the year ended December 31, 2025, up 11% YoY from $6.1M, driven by robust growth in medical case management (+42% to $2.2M) and utilization review (+5% to $2.2M), while HCO declined 2%, medical bill review fell 4%, and other revenues dropped 70%. Net income rose 57% to $1.4M from $0.9M, bolstered by 17% higher operating income and $0.4M in other income (none prior year), though total expenses increased 10% due to jumps in professional fees (+55%) and data maintenance (+131%). Cash from operations improved to $1.2M from $0.7M, with total assets growing to $13.5M.

• ·Basic and diluted EPS: $0.11 (2025) vs $0.07 (2024)
• ·Total expenses: $5.7M (2025) vs $5.2M (2024), +10%
• ·Investments: $10.0M (Dec 31 2025) vs $9.0M (2024)
• ·Current liabilities decreased to $0.4M from $0.7M
• ·Net cash used in investing: ($1.0M) vs ($1.1M)
• ·Retained earnings: $12.6M (2025) vs $11.3M (2024)

18-03-2026

Boston Scientific Corporation (BSX) filed Definitive Additional Proxy Materials (DEFA14A) on March 18, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and appears to be a notice related to proxy statement availability via the internet. No specific proposals, financial data, or voting matters are detailed in the provided content.

• ·Filing classified as Definitive Additional Materials under Schedule 14A.

18-03-2026

Newbridge Acquisition Limited, a blank check company, announced on March 18, 2026, that commencing March 23, 2026, holders of its units (NBRGU) may elect to separately trade the underlying Class A ordinary shares (NBRG) and rights (NBRGR) on The Nasdaq Capital Market. Each unit consists of one Class A ordinary share and one right entitling the holder to one-eighth of one Class A ordinary share upon consummation of an initial business combination. Unseparated units will continue trading under NBRGU, and holders must contact transfer agent VStock Transfer LLC for separation.

• ·IPO registration statement (File No. 333-289966) effective September 30, 2025; post-effective amendment effective December 18, 2025.
• ·No fractional rights issued upon unit separation.
• ·Company incorporated in British Virgin Islands with principal offices in Wanchai, Hong Kong.

18-03-2026

CalciMedica, Inc. received Nasdaq notices on March 13, 2026, for failing the MVLS Requirement (market value below $35M for 30 consecutive business days), and also not meeting stockholders' equity or net income standards under Listing Rules 5550(b)(1) and 5550(b)(3); a separate notice on March 16, 2026, cited failure of the minimum bid price requirement (below $1.00/share for 30 days). The company has 180 calendar days to regain compliance—until September 9, 2026, for MVLS/equity/net income, and September 14, 2026, for bid price—with options like reverse stock split, but there is no assurance of success and trading continues uninterrupted under symbol CALC.

• ·Company address: 505 Coast Boulevard South, Suite 307, La Jolla, California 92037
• ·Trading symbol: CALC
• ·Notifications have no immediate effect on listing or trading

18-03-2026

PennyMac Financial Services, Inc. amended and restated its bylaws, focusing on Article I Stockholders, which governs annual and special meetings, notice requirements, quorums, voting, proxies, record dates, and written consents. Special meetings can now be called by stockholders with at least 25% voting power (initially), automatically increasing to 51% when certain common stock holders exceed 51% ownership excluding legacy Private National Mortgage Acceptance Company affiliates. Notice periods remain standardized at 10-60 days with no quorum or voting changes indicating material shifts.

• ·Notice of stockholder meetings: not more than 60 days nor less than 10 days prior
• ·Adjournment notice required if more than 30 days
• ·Written consents effective within 60 days of earliest consent
• ·Stockholder list prepared at least 10 days before meetings

18-03-2026

Cingulate Inc. filed a DEFA14A supplement on March 18, 2026, to its March 2 proxy statement for the special stockholder meeting on March 24, 2026, correcting an administrative error in the security ownership table by adding Falcon Creek Capital Advisor LLC as a beneficial owner of 1,951,946 shares (18.16%) of common stock as of February 13, 2026. Directors and executive officers as a group beneficially own 484,688 shares (4.41%), with individual holdings under 2%. No other modifications to the original proxy statement.

• ·Laurie A. Myers employment terminated on August 7, 2025; her beneficial ownership reflects vested stock options.
• ·Falcon Creek shares from Private Placement; excludes 954 preferred shares and 1,712,062 warrant shares pending stockholder approval of Issuance Proposal.
• ·Address for listed stockholders (except Falcon Creek): 1901 W. 47th Place, Kansas City, KS 66205.

18-03-2026

Elvictor Group Inc. (ELVG) announced approval by its Board and stockholders representing 90.3% of voting power for a 1-for-500 reverse stock split, reducing outstanding common shares from approximately 414.4 million to 0.83 million while keeping authorized shares unchanged. The move is intended to support a higher per-share trading price and the company's uplisting strategy to a national securities exchange. No fractional shares will be issued, with any fractions rounded up to the nearest whole share.

• ·Reverse split approved via written consent without a stockholder meeting.
• ·Trading symbol ELVG will temporarily append 'D' (ELVGD) for 20 business days starting March 17, 2026.
• ·Split expected to become effective after required notice period and filings with State of Nevada and FINRA.

18-03-2026

Hewlett Packard Enterprise Company announced the launch and pricing of a $2B aggregate principal amount senior unsecured Notes offering on March 16, 2026, consisting of $300M Floating Rate Notes due 2028, $500M 4.500% Notes due 2028, $600M 4.600% Notes due 2029, and $600M 5.250% Notes due 2033. The Notes are expected to close on March 23, 2026, subject to customary conditions, and were underwritten by Barclays Capital Inc., BofA Securities, Inc., SG Americas Securities, LLC, and Wells Fargo Securities, LLC. The offering is registered under Form S-3 (No. 333-276221).

• ·Notes rank equally with all existing and future senior unsecured indebtedness
• ·Underwriting Agreement dated March 16, 2026, filed as Exhibit 1.1
• ·Registration statement on Form S-3 (No. 333-276221), effective December 22, 2023

18-03-2026

At Pineapple Financial Inc.'s 2026 Annual Meeting of Stockholders on March 13, 2026, shareholders elected six directors—Shubha Dasgupta, Kendall Marin, Drew Green, Paul Baron, Tasis Giannoukakis, and Anthony Georgiades—each receiving majority support ranging from approximately 79% (Dasgupta and Georgiades) to 91% (others). Shareholders also ratified MNP LLP as the independent auditors for the fiscal year ending August 31, 2026, with 86.8% votes in favor (2,709,116.09 shares). While all proposals passed decisively, Dasgupta and Georgiades faced relatively higher opposition with around 180,000 votes against each.

• ·Meeting results filed on March 18, 2026
• ·Company is an emerging growth company
• ·Common Shares traded as PAPL on NYSE American

18-03-2026

Core Scientific, Inc./tx (CIK 0001839341), a company in crypto assets with SIC 6199 (Finance Services), filed a 10-K/A amendment on March 18, 2026. The provided EDGAR search results highlight intense recent activity including multiple 13D/A and 13G/A filings signaling changes in beneficial ownership by major shareholders, several 10-Q/A amendments, a recent 10-K filing on March 2, 2026, and an 8-K on March 6, 2026 covering material agreements and other events. No specific financial metrics, period-over-period comparisons, or performance data are available in the filing list.

• ·Company address: 838 Walker Road Suite 21-2105, Dover, DE 19904
• ·Fiscal year end: December 31
• ·Recent filings include contested proxy materials (DFAN14A, DEFC14A, DEFM14A) and merger communications (425 filings) indicating potential acquisition activity
• ·CF Office designation: 09 Crypto Assets

18-03-2026

NewtekOne, Inc. entered into a Securities Distribution Agreement on March 13, 2026 (effective March 12, 2026) with B. Riley Securities, Inc., Compass Point Research and Trading, LLC, and Roth Capital Partners, LLC, enabling at-the-market offerings of up to $50 million aggregate principal amount/liquidation preference of specified senior notes and depositary shares. The securities will be issued under the Company's shelf registration statement on Form S-3 (File No. 333-269452) and a prospectus supplement filed on March 13, 2026. No sales have occurred under this agreement to date.

• ·Agreement filed as Exhibit 1.1
• ·Prospectus Supplement filed with SEC on March 13, 2026
• ·Shelf registration statement: Form S-3 (File No. 333-269452)
• ·Company principal executive offices: 4800 T Rex Avenue, Suite 120, Boca Raton, Florida 33431

18-03-2026

Abra Financial Holdings, Inc. CEO Bill Barhydt discussed the recently signed Business Combination Agreement with New Providence Acquisition Corp. III (dated March 16, 2026) in a Schwab TV interview, positioning Abra as a trusted wealth management platform for crypto assets via its Bitcoin bank model, with plans to file an S-4 soon and list as ABRX by summer 2026. Barhydt expressed optimism on Bitcoin's long-term upside as a liquidity hedge amid money printing and geopolitical tensions, but noted current market volatility including the S&P 500 being 5% off highs and entry volatility averaging 25%. No financial metrics for Abra were disclosed.

• ·Business Combination Agreement signed March 16, 2026
• ·S-4 registration statement to be filed soon with SEC
• ·Expected listing timeline: sometime summer 2026
• ·Interview aired March 18, 2026 at 9:40am ET on Schwab TV Opening Bell

18-03-2026

Sound Financial Bancorp, Inc. (SFBC) reported net income of $7.2M for 2025, up 54% YoY from $4.6M, supported by net interest income growth of 13% to $34.9M, NIM expansion to 3.45% from 3.00%, and total assets increasing 10% to $1.09B with deposits up 13% to $949M. Nonperforming assets improved to $6.1M or 0.56% of total assets from $7.5M or 0.75%. However, noninterest income declined 15% to $4.0M, loan portfolio growth was nearly flat at +0.6% to $897M net, and noninterest expenses remained flat at -$0.1% to $30.1M.

• ·Nonaccrual loans decreased 23% YoY to $5.8M from $7.5M.
• ·Provision for credit losses was $0.1M in 2025 vs release of $0.1M in 2024.
• ·Fair value adjustment on MSRs was negative $0.7M in 2025 vs -$0.004M in 2024.

18-03-2026

AmeriServ Financial Inc reported net income of $5.6M for the year ended December 31, 2025, up 56% YoY from $3.6M, driven by net interest income growth of 17.2% to $42.3M on higher interest income (+7.3%) and lower interest expense (-4.5%), with ROA improving to 0.39% and ROE to 5.03%. However, loans declined 3.3% YoY to $1.03B, provision for credit losses surged to $4.1M from $0.9M, and non-interest income fell slightly to $17.0M while non-interest expenses remained flat at around $48M. Total assets grew modestly 2.2% to $1.45B, supported by 3.9% deposit growth to $1.25B.

• ·Non-performing loans declined to $8.3M (0.80% of loans) from $10.9M (1.02%) YoY.
• ·Net interest margin improved to 3.15% from 2.81% YoY.
• ·Cash dividends per share held flat at $0.12 for 2025.
• ·Book value per share rose to $7.22 from $6.49 YoY.
• ·Total borrowed funds decreased to $75.3M from $101.7M YoY.

18-03-2026

Artelo Biosciences, Inc. entered into securities purchase agreements on March 12, 2026, issuing 12% bridge notes to Vanquish Funding Group Inc. (principal $237,300, proceeds $210,000) and Boot Capital LLC (principal $113,000, proceeds $100,000), raising $310,000 gross for general working capital amid high costs including original issue discounts and $10,000 legal fees. The notes mature January 15, 2027, are prepayable without penalty, but feature risky terms like 150% default acceleration and conversion rights at a discount (greater of $0.125 or 75% of recent low trading price), capped at 4.99% beneficial ownership to limit immediate dilution.

• ·Notes issued in reliance on Section 4(a)(2) and Rule 506(b) of Regulation D, unregistered securities.
• ·Conversion price is the greater of $0.125 or 75% of the lowest trading price over the prior 10 trading days.
• ·Exhibits include Purchase Agreements (10.1, 10.2) and Notes (10.3, 10.4).

18-03-2026

Cincinnati Financial Corporation's DEF 14A proxy statement for the 2026 Annual Meeting on May 2, 2026 (record date March 4, 2026) seeks approval for director elections, amendments to Articles of Incorporation to reduce special shareholder meeting threshold from 50% to 25%, advisory vote on executive compensation, and auditor ratification, with the board recommending FOR on most items except a nonbinding shareholder proposal (AGAINST). Recent governance improvements include 2025 adoption of simple majority voting (shareholder-approved) and addition of independent director Edward S. Wilkins, resulting in a 14-member board that is >71% independent (>35% diverse), with 6 new directors since 2019 and average independent tenure of 12 years. The company emphasizes strong practices like proxy access (3% ownership for 3 years), no poison pill, performance-based NEO pay, stock ownership guidelines (5x salary for CEO), and comprehensive sustainability reporting.

• ·Annual meeting location: Cincinnati Art Museum, 953 Eden Park Drive, Cincinnati, Ohio 45202 at 9:30 a.m. ET.
• ·Board recommendations: FOR Election of Directors, FOR Amended Articles, AGAINST Nonbinding Shareholder Proposal, FOR Advisory Vote on Exec Comp, FOR Ratification of Auditors.
• ·Average tenure of 10 independent directors: 12 years.
• ·Proxy access allows shareholder/group of up to 20 holding 3% shares for 3 years to nominate greater of 2 seats or 20% of board.

18-03-2026

Lifeward reported Q4 2025 revenue of $5.1M, down 33% YoY due to declines in AlterG (-43%) and MyoCycle (-90%), though partially offset by 20% growth in ReWalk Personal to $1.8M; full-year revenue fell 14% to $22.0M with ReWalk Personal down 3%, MyoCycle -50%, and AlterG -18%. Operating expenses declined 25% FY GAAP to $28.1M and 12% non-GAAP to $24.1M, while GAAP gross margin improved to 38.2% from 32.0%, but adjusted operating loss widened 22% in Q4 to $4.0M. Strategic progress includes shareholder approval for Oramed POD™ acquisition with up to $47M funding and upper-body exoskeleton purchase, amid low $2.2M cash position.

• ·Upper-body exoskeleton expected commercial launch in 18-24 months.
• ·International distribution expansion to Mexico, Thailand, United Arab Emirates via Verita Neuro.
• ·Collaboration with Shirley Ryan AbilityLab for clinical research and training.

18-03-2026

First Financial Corporation (THFF) declared a quarterly dividend of $0.56 per share, payable on April 15, 2026, to shareholders of record on April 1, 2026. The announcement was issued via press release on March 18, 2026, as part of an 8-K filing under Items 8.01 and 9.01.

• ·Filing dated March 18, 2026, reporting event of March 17, 2026
• ·Common Stock trading symbol: THFF, par value $0.125 per share

18-03-2026

Average total assets declined 8.1% YoY to $778.8M in 2025 from $846.8M, driven by sharp deposit contraction of 7.6% to $655.1M and securities reductions, while net average loans grew modestly 3.4% to $241.3M. Net interest income fell 13.1% to $20.6M with NIM contracting 0.14 points to 2.91%, though shareholders' equity surged 25.5% to $95.9M; period-end total assets dropped further 12.6% to $727.1M with deposits down 16.1% but gross loans up 12.9% to $263.7M.

• ·Average loan yield declined to 6.08% in 2025 from 6.26% in 2024.
• ·Interest expense decreased 15.5% YoY to $8.1M in 2025.
• ·Period-end shareholders' equity $100.7M as of Dec 31, 2025, up 11.9% YoY.
• ·Allowance for credit losses on loans $2.9M (Dec 31, 2025) vs $3.0M (2024).
• ·Audited by EisnerAmper LLP (PCAOB ID 247).

18-03-2026

CIM Real Estate Finance Trust, Inc., as guarantor, along with its subsidiaries entered into the Fifth Amendment to the Master Repurchase and Securities Contract with Wells Fargo Bank, National Association, dated March 12, 2026, primarily updating the definition of the Fee Letter to a Fifth Amended and Restated version. The amendment reaffirms that all existing obligations, liens, and security interests under the original agreement (dated May 20, 2021, with prior amendments) remain in full force without modification or reduction, and no Defaults or Events of Default exist. Seller agrees to pay Buyer's reasonable legal fees from Moore & Van Allen, PLLC, per invoice.

• ·Original Master Repurchase Agreement dated May 20, 2021
• ·Prior amendments: October 28, 2021 (First); February 14, 2022 (Amended and Restated Confirmation effective December 23, 2021); March 4, 2022 (Second); August 31, 2022 (Third); August 15, 2025 (Fourth)
• ·Legal fees payable within 10 Business Days of invoice if not paid at closing

18-03-2026

Ally Financial Inc. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Shareholders on May 6, 2026, held virtually. Proposals include election of 12 director nominees, advisory vote on executive compensation, ratification of Deloitte & Touche LLP as 2026 independent auditors, approval of the Incentive Compensation Omnibus Plan and Employee Stock Purchase Plan, and a shareholder proposal to reduce the threshold for calling special meetings (Board recommends against). Shareholders must vote by May 5, 2026, 11:59 PM ET, with proxy materials available online or by request before April 22, 2026.

• ·Annual Meeting time: 9:00 AM ET on May 6, 2026, virtually at www.virtualshareholdermeeting.com/ALLY2026
• ·Proxy materials request deadline: April 22, 2026
• ·Voting platform: www.ProxyVote.com/ALLY

18-03-2026

Newton Golf Company, Inc. (NWTG) entered into a Securities Purchase Agreement dated March 2026 to issue convertible promissory notes and warrants to accredited investors for an aggregate principal amount of up to $2.0 million across initial and additional closings. The Notes are convertible into shares of Common Stock (par value $0.01), and Warrants are exercisable for additional Common Stock shares. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Filing date: March 18, 2026
• ·SEC 8-K Items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 9.01 (Financial Statements and Exhibits)
• ·Common Stock par value: $0.01 per share
• ·Purchasers are accredited investors; securities offered under exemptions from federal and state securities registration